“I find little other reasonable explantation for the jubilation that Dr. Pourhassan was doing a really poor job of containing in his late Friday Proactive interview.”

NP has long been excited about leronlimab and the various potential indications. He was excited about HIV and then cancer, giving many, many interviews smiling and showing excitement. The majority of those interviews and NP’s jubilation did not proceed a major data release and were instead just updates or updates following PRs.

My point is this: I wouldn’t use NP’s excitement in yesterday’s Proactiv video as an indicator that he saw the M2M data and that the data is good, especially considering that yesterday the data had most likely not yet been analyzed by Amarex. However, he had seen all of the data and results related to the 65 EIND patients and is likely assuming the data from the M2M trial will be the same.